Sally M. Hunter

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes

Sally M. Hunter, Michael S. Anglesio, Georgina L. Ryland et al. · Oncotarget · 2015 · 199 citations · Full text

Medicine, Genetics, Oncology +17

The molecular origin and taxonomy of mucinous ovarian carcinoma

Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland et al. · Nature Communications · 2019 · 187 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors

Georgina L. Ryland, Sally M. Hunter, Maria Doyle et al. · Genome Medicine · 2015 · 161 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Patient-derived Xenografts Reveal that Intraductal Carcinoma of the Prostate Is a Prominent Pathology in BRCA2 Mutation Carriers with Prostate Cancer and Correlates with Poor Prognosis

Gail P. Risbridger, Renea A. Taylor, David Clouston et al. · European Urology · 2014 · 137 citations

Medicine, Oncology, Urology +16

Thymic lymphomas in mice with a truncating mutation in Brca2.

Lori S. Friedman, Fiona Thistlethwaite, Khyati Patel et al. · PubMed · 1998 · 132 citations

Life Sciences, Genetics, Oncology +13